Primary Recommendation

EKF - Second large diagnostic deal sends EKF full square into the US market

July 2011

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

Julian Baines and David Evans, chief executive and chairman respectively of EKF, are both experts in building up medical diagnostic businesses. In 2007, they sold BBI, their first diagnostic business, which they had built up since 2000, to Alere for £84m. Under their stewardship, during that seven year stint the business grew sales from £1m to £35m.Now the duo are involved in a similar reconstruction at EKF, which is also targeting diagnostics. EKF has been born out of the cash shell known as International Brand Licencing, which they took control of in 2009 when they changed its strategy from sports apparel to focus on diagnostics. Progress has been nothing short of dramatic, with the legacy ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Hornby - Olympic excitement to build as year progresses

Character

EKF Diagnostics (January 2015)

EKF Diagnostics (October 2014)

EKF Diagnostics (June 2014)

EKF Diagnostics - Three acquisitions in a month (April 2014)

EKF Diagnostics (March 2014)

EKF Diagnostics (October 2013)

EKF Diagnostics (April 2013)

EKF Diagnostics (October 2012)

EKF - Forecasts upgraded again (April 2012)

EKF DIagnostics (October 2011)

EKF Diagnostics (December 2010)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X